Evidence map›Paper›PMID 34463132›Full record

ArticleCirculation. Genomic and precision medicine2021

Polygenic Risk Score to Identify Subclinical Coronary Heart Disease Risk in Young Adults.

Quinn S Wells, Minoo Bagheri, Aaron W Aday, Deepak K Gupta, Christian M Shaffer, Wei-Qi Wei, Nataraja Sarna Vaitinadin, Sadiya S Khan, Philip Greenland, Thomas J Wang and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation. Genomic and precision medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Clinical utility of polygenic risk scores in cardiovascular disorders.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. IntronicInternational journal of molecular sciences · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Observational
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Quinn S WellsDepartment of Medicine (Q.S.W., M.B., A.W.A., D.K.G., C.M. Shaffer, W.-Q.W., N.S.V., C.M. Stein, D.M.R., J.D.M.), Vanderbilt University Medical Center.ORCID 0000-0003-3899-0313
Minoo BagheriDepartment of Medicine (Q.S.W., M.B., A.W.A., D.K.G., C.M. Shaffer, W.-Q.W., N.S.V., C.M. Stein, D.M.R., J.D.M.), Vanderbilt University Medical Center.ORCID 0000-0002-6093-613X
Aaron W AdayDepartment of Medicine (Q.S.W., M.B., A.W.A., D.K.G., C.M. Shaffer, W.-Q.W., N.S.V., C.M. Stein, D.M.R., J.D.M.), Vanderbilt University Medical Center.ORCID 0000-0001-6243-3432
Deepak K GuptaDepartment of Medicine (Q.S.W., M.B., A.W.A., D.K.G., C.M. Shaffer, W.-Q.W., N.S.V., C.M. Stein, D.M.R., J.D.M.), Vanderbilt University Medical Center.ORCID 0000-0003-2191-3485
Christian M ShafferDepartment of Medicine (Q.S.W., M.B., A.W.A., D.K.G., C.M. Shaffer, W.-Q.W., N.S.V., C.M. Stein, D.M.R., J.D.M.), Vanderbilt University Medical Center.
Wei-Qi WeiDepartment of Medicine (Q.S.W., M.B., A.W.A., D.K.G., C.M. Shaffer, W.-Q.W., N.S.V., C.M. Stein, D.M.R., J.D.M.), Vanderbilt University Medical Center.ORCID 0000-0003-4985-056X
Nataraja Sarna VaitinadinDepartment of Medicine (Q.S.W., M.B., A.W.A., D.K.G., C.M. Shaffer, W.-Q.W., N.S.V., C.M. Stein, D.M.R., J.D.M.), Vanderbilt University Medical Center.ORCID 0000-0003-0145-0348
Sadiya S KhanDepartment of Preventive Medicine (S.S.K., P.G.), Northwestern University Feinberg School of Medicine, Chicago, IL.ORCID 0000-0003-0643-1859
Philip GreenlandDepartment of Preventive Medicine (S.S.K., P.G.), Northwestern University Feinberg School of Medicine, Chicago, IL.ORCID 0000-0002-6327-2439
Thomas J WangDepartment of Internal Medicine, UT Southwestern Medical Center, Dallas, TX (T.J.W.).ORCID 0000-0003-4063-6508
C Michael SteinDepartment of Medicine (Q.S.W., M.B., A.W.A., D.K.G., C.M. Shaffer, W.-Q.W., N.S.V., C.M. Stein, D.M.R., J.D.M.), Vanderbilt University Medical Center.
Dan M RodenDepartment of Medicine (Q.S.W., M.B., A.W.A., D.K.G., C.M. Shaffer, W.-Q.W., N.S.V., C.M. Stein, D.M.R., J.D.M.), Vanderbilt University Medical Center.ORCID 0000-0002-6302-0389
Jonathan D MosleyDepartment of Medicine (Q.S.W., M.B., A.W.A., D.K.G., C.M. Shaffer, W.-Q.W., N.S.V., C.M. Stein, D.M.R., J.D.M.), Vanderbilt University Medical Center.ORCID 0000-0001-6421-2887
Maine Farmland Trust · USVanderbilt University · USGTx (United States) · USNorthwestern University · USSouthwestern Medical Center · US

Funding

FRAMINGHAM HEART STUDY - YEAR 5 EXAM75N92019D00031 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · 2019 to 2024
$29.8M
Understanding and preventing HLA-associated drug reactionsP50GM115305 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RODEN, DAN M · 2015 to 2019
$13.0M
VGER, the Vanderbilt Genome-Electronic Records ProjectU01HG008672 · NHGRI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DENNY, JOSHUA C., RODEN, DAN M · 2015 to 2019
$5.1M
VGM: Vanderbilt Genomic Medicine Training ProgramT32HG008341 · NHGRI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Nancy J Cox, Joseph F. Peterson · 2016 to 2026
$2.8M
Virtual metabolomics as a discovery tool for novel cardiometabolic disease biologyR01HL142856 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FERGUSON, JANE F, MOSLEY, JONATHAN DAVID · 2019 to 2023
$2.7M
Leveraging common genetic variation to reduce misclassification of non-diseased individuals and unnecessary health care utilization attributable to surrogate biomarkersR01GM130791 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MOSLEY, JONATHAN DAVID · 2019 to 2023
$2.3M
Genomic and Phenomic Architecture of Heart FailureR01HL140074 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WELLS, QUINN STANTON · 2018 to 2022
$2.0M
The Vanderbilt Emergency Care Research Training ProgramK12HL133117 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STORROW, ALAN B · 2016 to 2020
$1.9M
PheMAP: Measured, Automated Profile to Facilitate High Throughput PhenotypingR01GM139891 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WEI, WEI-QI · 2021 to 2024
$1.7M
Pharmacogenetics to improve drug therapyR35GM131770 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STEIN, CHARLES M. · 2019 to 2023
$1.7M
Exploring Statin Pleiotropic Effects within a Very Large EHR Cohort - Diversity SupplementR01HL133786 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WEI, WEI-QI · 2017 to 2020
$1.7M
The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery DiseaseK23HL151871 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ADAY, AARON W. · 2021 to 2025
$927k
American Heart Association-American Stroke Association 16FTF30130005NHGRI NIH HHS T32 HG008341NHGRI NIH HHS U01 HG008672NHLBI NIH HHS 75N92019D00031NHLBI NIH HHS HHSN268201500001CNHLBI NIH HHS HHSN268201500001INHLBI NIH HHS K12 HL133117NHLBI NIH HHS K23 HL151871NHLBI NIH HHS N01 HC025195NHLBI NIH HHS R01 HL133786NHLBI NIH HHS R01 HL140074NHLBI NIH HHS R01 HL142856NIGMS NIH HHS P50 GM115305NIGMS NIH HHS R01 GM130791NIGMS NIH HHS R01 GM139891NIGMS NIH HHS R35 GM131770
6 · The paper itself

Abstract

backgroundPolygenic risk scores (PRS) may enhance risk stratification for coronary heart disease among young adults. Whether a coronary heart disease PRS improves prediction beyond modifiable risk factors in this population is not known.

methodsGenotyped adults aged 18 to 35 years were selected from the CARDIA study (Coronary Artery Risk Development in Young Adults; n=1132) and FOS (Framingham Offspring Study; n=663). Systolic blood pressure, total and HDL (high-density lipoprotein) cholesterol, triglycerides, smoking, and waist circumference or body mass index were measured at the visit 1 exam of each study, and coronary artery calcium, a measure of coronary atherosclerosis, was assessed at year 15 (CARDIA) or year 30 (FOS). A previously validated PRS for coronary heart disease was computed for each subject. The C statistic and integrated discrimination improvement were used to compare improvements in prediction of elevated coronary artery calcium between models containing the PRS, risk factors, or both.

resultsThere were 62 (5%) and 93 (14%) participants with a coronary artery calcium score >20 (CARDIA) and >300 (FOS), respectively. At these thresholds, the C statistic changes of adding the PRS to a risk factor-based model were 0.015 (0.004-0.028) and 0.020 (0.001-0.039) in CARDIA and FOS, respectively. When adding risk factors to a PRS-based model, the respective changes were 0.070 (0.033-0.109) and 0.051 (0.017-0.079). The integrated discrimination improvement, when adding the PRS to a risk factor model, was 0.027 (-0.006 to 0.054) in CARDIA and 0.039 (0.0005-0.072) in FOS.

conclusionsAmong young adults, a PRS improved model discrimination for coronary atherosclerosis, but improvements were smaller than those associated with modifiable risk factors.

Indexed as

AdolescentAdultBody Mass IndexCalciumCholesterol, HDLCohort StudiesCoronary DiseaseFemaleHumansMaleRiskRisk AssessmentSmokingTriglyceridesYoung AdultCalciumCholesterol, HDLTriglyceridesatherosclerosisblood pressurecoronary arteryheart diseaserisk factors

Identifiers

PMID34463132
PMCPMC8530876
OpenAlexW3198104045

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.